Related Experiment Videos
One Japanese MODY family with severe and progressive microangiopathies
Abstract:
Recently we investigated maturity-onset diabetes of the young (MODY) with severe and progressive microangiopathies in one Japanese family. The proband was a female who was diagnosed as having diabetes when she was 11 years old, and was controlled without insulin for 9 years. She is now 30 years old and has been suffering from proliferative retinopathy since the age of 20. Her maternal grandfather, mother, uncle, and younger sister are also diabetic with severe microangiopathies. MODY is a concept which was first put forward by Tattersall and Fajans in 1975. It was defined as a form of diabetes diagnosed before the age of 25 years, controlled without insulin for more than 2 years and demonstrating dominant heredity over more than three generations. Most Western papers have reported few microangiopathies in the MODY patient, but our findings run counter to this description.
Insights
Maturity-onset diabetes of the young (MODY) in a Japanese family presented with severe microangiopathies, challenging typical Western observations. This finding highlights genetic and phenotypic diversity in MODY diabetes.
Area of Science:
- Endocrinology
- Genetics
- Ophthalmology
Background:
- Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes.
- Typically, MODY is characterized by dominant inheritance and absence of microvascular complications.
Observation:
- A Japanese family exhibited a distinct form of MODY with severe, progressive microangiopathies.
- The proband developed proliferative retinopathy at age 20, despite diabetes onset at 11 and 9 years of insulin-free remission.
Findings:
- The family demonstrated a strong hereditary pattern of diabetes with severe microvascular complications across multiple generations.
- This contrasts with Western reports of MODY, which usually show minimal microangiopathy.
Implications:
- These findings suggest significant genetic and phenotypic heterogeneity within MODY subtypes.
- Further research is needed to understand the mechanisms driving microangiopathy in this specific MODY cohort.
- This case underscores the importance of considering diverse clinical presentations in diagnosing and managing MODY.